Showing results (81-90 of 135) with videos related to
Sort By:
Pageof 14
Archives of Pathology & Laboratory Medicine|January 28, 2020
Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant FrequenciesAlissa Keegan, Julia A Bridge, Neal I Lindeman, et al.The Journal of Molecular Diagnostics : JMD|November 19, 2016
Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation SequencingJonathan A Nowak, Matthew B Yurgelun, Jacqueline L Bruce, et al.Archives of Pathology & Laboratory Medicine|April 11, 2019
Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology CommitteeJoel T Moncur, Angela N Bartley, Julia A Bridge, et al.JAMA Oncology|December 16, 2017
Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS TestingAnnette S Kim, Angela N Bartley, Julia A Bridge, et al.The Journal of Molecular Diagnostics : JMD|July 1, 2020
Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing PlatformsHarrison K Tsai, Diane G Brackett, David Szeto, et al.Archives of Pathology & Laboratory Medicine|October 31, 2018
Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology AssaysJason D Merker, Kelly Devereaux, A John Iafrate, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2022
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical OpinionDebyani Chakravarty, Amber Johnson, Jeffrey Sklar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancerDavid M Jackman, Beow Y Yeap, Neal I Lindeman, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 7, 2016
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomasLauren L Ritterhouse, Jonathan A Nowak, Kyle C Strickland, et al.American Journal of Clinical Pathology|August 15, 2025
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implicationsAli AlJabban, Roberta S Azevedo, Katherine Antel, et al.Pageof 14